CSTONE PHARMA-B (02616) has announced a share repurchase transaction. On June 22, 2026, the company purchased 500,000 of its own shares on the market.

The total consideration for the buyback was approximately HK$2.35 million. The repurchase price per share ranged between HK$4.67 and HK$4.74.